Posts Tagged ‘canagliflozin’

Cana/Phen: Unlocking a Potential New Drug Combination

March 30, 2017 — A new study in Diabetes Care provides tantalizing new data on a potential new combination drug for obesity: cana/phen. The study compared a combination of 300 mg of canagliflozin and 15 mg phentermine to each drug alone and to placebo. It was a randomized, controlled study that lasted 26 weeks. The combination was more effective than […]

Progress on a New Combination for Obesity Treatment

June 13, 2016 — Late-breaking data presented this past weekend at the Scientific Sessions of the American Diabetes Association provides a good look at the efficacy of a new combination drug treatment for obesity. The combination is 300 mg of canagliflozin (Invokana) and 15 mg of phentermine. The combination of these two drugs produced an average weight loss of 7.5% […]

Diabetes Spawning More Options for Obesity Care

May 21, 2015 — People living with obesity are finally beginning to see more options for obesity care and, in part, they can thank competition to innovate in diabetes care for some of this progress. A particularly visible example of this is liraglutide, which has been available for treating type 2 diabetes since 2009. After six years of use […]